Balugrastim

BIOLOGICAL2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Chemotherapy-induced NeutropeniaSolid Tumors

Phase 2

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

CompletedNCT00837265

Teva Branded Pharmaceutical Products R&D, Inc.Chemotherapy-induced Neutropenia

Start: 2008-08-21End: 2009-06-26Updated: 2024-04-03

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

WithdrawnNCT01940601

Teva Branded Pharmaceutical Products R&D, Inc.Solid Tumors

Start: 2014-09-30End: 2015-12-31Updated: 2015-01-14